Sam A Pharm Co Stock Five Year Return

009300 Stock  KRW 17,310  240.00  1.37%   
Sam A Pharm Co fundamentals help investors to digest information that contributes to Sam A's financial success or failures. It also enables traders to predict the movement of Sam Stock. The fundamental analysis module provides a way to measure Sam A's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sam A stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Sam A Pharm Co Company Five Year Return Analysis

Sam A's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.

Five Year Return

 = 

(Mean of Monthly Returns - 1)

X

100%

More About Five Year Return | All Equity Analysis
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition

According to the company disclosure, Sam A Pharm Co has a Five Year Return of 0.0%. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Pharmaceuticals (which currently averages 0.0) industry. This indicator is about the same for all Republic of Korea stocks average (which is currently at 0.0).

Did you try this?

Run Share Portfolio Now

   

Share Portfolio

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Sam Fundamentals

About Sam A Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Sam A Pharm Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sam A using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sam A Pharm Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Sam A

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sam A position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sam A will appreciate offsetting losses from the drop in the long position's value.

Moving together with Sam Stock

  0.72102940 Kolon Life SciencePairCorr
  0.92074430 Aminologics CoLtdPairCorr

Moving against Sam Stock

  0.48230240 Hana Financial 7PairCorr
  0.45205470 HumasisPairCorr
  0.34023910 Daihan PharmaceuticalPairCorr
  0.32065660 AnterogenCoLtdPairCorr
The ability to find closely correlated positions to Sam A could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sam A when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sam A - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sam A Pharm Co to buy it.
The correlation of Sam A is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sam A moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sam A Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sam A can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Sam Stock

Sam A financial ratios help investors to determine whether Sam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sam with respect to the benefits of owning Sam A security.